income_security_and_social_services · health · HHS-NIH11

Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R21 - Clinical Trial Optional)

National Institutes of Health · PAR-25-266

447 days left

Award Range

$0 – $200K

Total Program Funding

$200K

Deadline

November 16, 2027

GRANTQUICK SUMMARYPlain-English Overview

Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R21 - Clinical Trial Optional). National Institutes of Health. This FOA encourages research relevant to the development of novel screening approaches and/or therapeutic interventions for potentially fatal or disabling conditions that have been identified through newborn screening, as well as for "high priority" genetic conditions where screening may be... up to $200,000 per award; $200,000 total program funding.

Who Should Apply

State governments, County governments, Nonprofits (501c3), Other Native American Tribal Organizations, Public universities/colleges (+10 more)

Who Should NOT Apply

Organizations not matching the eligible applicant types listed above

Key Requirements (Plain English)

•Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Is...
•Deadline: 2027-11-16

💡 GrantQuick Tip

Focus your proposal on clear outcomes, alignment with agency priorities, and demonstrate organizational capacity.

Competitiveness: Moderate to high — federal grants are always competitive

What This Grant Funds

This FOA encourages research relevant to the development of novel screening approaches and/or therapeutic interventions for potentially fatal or disabling conditions that have been identified through newborn screening, as well as for "high priority" genetic conditions where screening may be possible in the near future.Having an accurate screening test, as well as demonstrating the benefits of early intervention or treatment, are important criteria for including a condition on a newborn screening panel. This FOA defines a "high priority" condition as one where screening is not currently recommended, but infants with the condition would significantly benefit from early identification and treatment.

Attachments

PDF

PAR-25-266 Full Announcement Text

PAR-25-266-Full-Announcement.html

Who Can Apply

Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.

Eligible Applicant Types

State GovernmentsCounty Governments501(c)(3) NonprofitsOther Tribal OrganizationsPublic Colleges & UniversitiesIndependent School DistrictsFederally Recognized Tribal GovernmentsSpecial District GovernmentsSmall BusinessesPublic And Indian Housing AuthoritiesOther (see NOFO for details)City/Township GovernmentsNonprofits without 501(c)(3)Private Colleges & UniversitiesFor-Profit Organizations

Funding Details

Maximum Award: $200K
Total Program Funding: $200K
Cost Sharing Required?: No
Funding Instrument: grant

Key Dates

Posted: December 2, 2024

Application Deadline: November 16, 2027 (447 days remaining)

Agency Contact

NIH Grants Information grantsinfo@nih.gov

grantsinfo@nih.gov

Ready to apply?

View the full NOFO and submit your application on Grants.gov

View on Grants.gov